Presentation TCT 2025 TCT 1249: First-in-Human Study of Coronary Cryotherapy for Stabilization of High-Risk Atherosclerotic Plaques Presenter: Carlos Collet October 26, 2025
Presentation TCT 2025 TCT 1251: Artificial intelligence-based volumetric evaluation of the fibrous cap: the maximum thin-cap index within 4 mm Presenter: Thijs Jan Luttikholt October 26, 2025
Presentation TCT 2025 TCT 1248: Computed Tomography Angiography-Derived Plaque Morphology and Biological Activity of Subclinical Atherosclerosis Related to Future Acute Myocardial Infarctoin Presenter: Jinying Zhou October 26, 2025
Presentation TCT 2025 TCT 1247: Frequency of Untreated Vulnerable Plaques When Using FFR to Guide Selection of Non-culprit Lesions for PCI in STEMI Patients Presenter: Luai Madanat October 26, 2025
Presentation TCT 2025 TCT 1250: Thin-cap fibroatheroma is the only type of coronary plaque associated with high vulnerability despite absence of ischemia: insights from a patient level pooled analysis of COMBINE (OCT-FFR) and PECTUS-obs prospective natural history studies. Presenter: Elvin Kedhi October 26, 2025
Presentation TCT 2025 TCT 1242: Photon-Counting Versus Energy-Integrating Detector-Computed Tomography for the Identification of Coronary High-Risk Plaques Presenter: Lionel Chong October 26, 2025
Presentation TCT 2025 TCT 1246: Intracoronary imaging plaque vulnerability characteristics predictors of MACE: an updated meta-analysis of adjusted observational studies Presenter: Riccardo Improta October 26, 2025
Presentation TCT 2025 TCT 1243: Multimodality Imaging in Acute MI (MIAMI Study): NIRS-IVUS and OCT of Vulnerable Plaques in Non-Infarct-Related Arteries in STEMI Patients Presenter: Samia Mazumder October 26, 2025
Presentation TCT 2025 TCT 1244: Inverse Association Between Body Mass Index and Coronary Plaque Vulnerability Assessed by NIRS-IVUS: : A Mechanistic Insight Into the Obesity Paradox Presenter: Woohyeun Kim October 26, 2025
Presentation TCT 2025 TCT 1241: Atherogenic Lipoproteins and Intraplaque Lipid Burden: Evidence from NIRS-IVUS in Statin-Naive Patients Presenter: Woohyeun Kim October 26, 2025
Presentation TCT 2025 TCT 1245: First-in-human Serial Assessment of Therapeutic Modification in Coronary Plaque using Optical Coherence Tomography-Fluorescence Lifetime Imaging Presenter: Dong Oh Kang October 26, 2025
Presentation TCT 2025 Recent Coronary Trials: Routine PCI in Vulnerable Plaque - PREVENT the Madness! Presenter: Gary S. Mintz October 26, 2025
Presentation TCT 2025 TCT 412: Comprehensive Multimodal Assessment of Vulnerable Coronary Plaque Integrating Angiographic-Based Murray’s QFR, Radial Wall Strain (RWS), IVUS-NIRS and CCTA Presenter: Stefano Galli October 26, 2025
News Opinion CV Team Dispatch September 2025 Dispatch for the CV Team L.A. McKeown September 30, 2025
News Conference News SCCT 2025 CT-Guided PCI Coming Soon to a Cath Lab Near You—If Not There Already Yael L. Maxwell July 31, 2025
Presentation TCT India 2025 Imaging to define the vulnerable plaque – modality, device choice, diagnostic characteristics, and image review Presenter: Gary S. Mintz July 25, 2025
News Daily News Rise in CV Risk Factors Tied to Vulnerable Plaque in ACS Patients Caitlin E. Cox July 14, 2025
News Conference News EuroPCR 2025 FLAVOUR Confirms Long-term Noninferiority of FFR vs IVUS to Guide PCI Yael L. Maxwell May 30, 2025
News Conference News EuroPCR 2025 Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI Michael O'Riordan May 20, 2025
News Daily News Cannabis Use Again Tied to Increased CVD Risk in Young People L.A. McKeown March 19, 2025